Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Morgan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Protocols|March 18, 2026
An Open-Source Workflow for Semi-Automated Spatial Profiling of Multiplex Immunofluorescent ImagesAlisha Dabb, Cynthia Morgan, Sophia Noble, et al.
Immunology and Cell Biology|September 30, 2022
BCL6 deletion in CD4 T cells does not affect Th2 effector mediated immunity in the skinJodie Chandler, Melanie Prout, Sam Old, et al.
Journal of Genetic Counseling|November 6, 2013
MPS II: adaptive behavior of patients and impact on the family systemMary Needham, Wendy Packman, Maxwell Rappoport, et al.
Pharmacology, Biochemistry, and Behavior|April 14, 2012
Rolapitant (SCH 619734): a potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferretsRuth A Duffy, Cynthia Morgan, Robert Naylor, et al.
Journal of Genetic Counseling|November 15, 2014
Health-Related Quality of Life in Patients with MPS IIMary Needham, Wendy Packman, Natasha Quinn, et al.
Mucosal Immunology|November 24, 2025
Natural Killer T follicular helper cell function permits germinal centre entry in nasal associated lymphoid tissueIsabelle Montgomerie, Jessica Cotterell, Theresa E Pankhurst, et al.
Journal of Surgical Education|September 2, 2018
Interprofessional Simulations to Inform Perioperative Facility Planning and DesignSamuel Torres-Landa, Christopher Neylan, Kristin Quinlan, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2010
Discovery of a series of potent, orally active α,α-disubstituted piperidine NK(1) antagonistsDong Xiao, Cheng Wang, Anandan Palani, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2011
Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A)Michel R Corboz, Maria A Rivelli, Kevin D McCormick, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Protocols|March 18, 2026
An Open-Source Workflow for Semi-Automated Spatial Profiling of Multiplex Immunofluorescent ImagesAlisha Dabb, Cynthia Morgan, Sophia Noble, et al.
Immunology and Cell Biology|September 30, 2022
BCL6 deletion in CD4 T cells does not affect Th2 effector mediated immunity in the skinJodie Chandler, Melanie Prout, Sam Old, et al.
Journal of Genetic Counseling|November 6, 2013
MPS II: adaptive behavior of patients and impact on the family systemMary Needham, Wendy Packman, Maxwell Rappoport, et al.
Pharmacology, Biochemistry, and Behavior|April 14, 2012
Rolapitant (SCH 619734): a potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferretsRuth A Duffy, Cynthia Morgan, Robert Naylor, et al.
Journal of Genetic Counseling|November 15, 2014
Health-Related Quality of Life in Patients with MPS IIMary Needham, Wendy Packman, Natasha Quinn, et al.
Mucosal Immunology|November 24, 2025
Natural Killer T follicular helper cell function permits germinal centre entry in nasal associated lymphoid tissueIsabelle Montgomerie, Jessica Cotterell, Theresa E Pankhurst, et al.
Journal of Surgical Education|September 2, 2018
Interprofessional Simulations to Inform Perioperative Facility Planning and DesignSamuel Torres-Landa, Christopher Neylan, Kristin Quinlan, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2010
Discovery of a series of potent, orally active α,α-disubstituted piperidine NK(1) antagonistsDong Xiao, Cheng Wang, Anandan Palani, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2011
Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A)Michel R Corboz, Maria A Rivelli, Kevin D McCormick, et al.
Pageof 1